Genetic signature detected in T cell receptors from patients with severe COVID-19
- PMID: 37720084
- PMCID: PMC10504482
- DOI: 10.1016/j.isci.2023.107735
Genetic signature detected in T cell receptors from patients with severe COVID-19
Abstract
Characterization of host genetic factors contributing to COVID-19 severity promises advances on drug discovery to fight the disease. Most genetic analyses to date have identified genome-wide significant associations involving loss-of-function variants for immune response pathways. Despite accumulating evidence supporting a role for T cells in COVID-19 severity, no definitive genetic markers have been found to support an involvement of T cell responses. We analyzed 205 whole exomes from both a well-characterized cohort of hospitalized severe COVID-19 patients and controls. Significantly enriched high impact alleles were found for 25 variants within the T cell receptor beta (TRB) locus on chromosome 7. Although most of these alleles were found in heterozygosis, at least three or more in TRBV6-5, TRBV7-3, TRBV7-6, TRBV7-7, and TRBV10-1 suggested a possible TRB loss of function via compound heterozygosis. This loss-of-function in TRB genes supports suboptimal or dysfunctional T cell responses as a major contributor to severe COVID-19 pathogenesis.
Keywords: Genetics; Genomics; Immunology; Virology.
© 2023 The Authors.
Conflict of interest statement
At the time of writing, M.C. is associated with Cambridge Precision Medicine Limited.
Figures





References
-
- Poletti P., Tirani M., Cereda D., Trentini F., Guzzetta G., Sabatino G., Marziano V., Castrofino A., Grosso F., Del Castillo G., et al. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy. JAMA Netw. Open. 2021;4:e211085. - PMC - PubMed
-
- CDC . Centers for Disease Control and Prevention; 2022. Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals.https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingco... - PubMed
-
- COVID-19 Host Genetics Initiative The COVID-19 Host Genetics Initiative (2020). The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur. J. Hum. Genet. 2020;28:715–718. doi: 10.1038/s41431-020-0636-6. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources